FQ-4

•    Inorganic and organic nanoparticulate systems for bio-imaging
•    Functionalized agents/devices for in vitro and in vivo imaging and diagnostics
•    Theranostic nanocarriers, multimodal theranostic agents
•    Multifunctional theranostic nanoplatforms
•    Biomedical imaging (MRI, MPI, PET, SPECT, ... )